Rosen Law Firm, a global legal practice specializing in investor rights, has issued a reminder to individuals who purchased agilon health, inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025. The firm is representing investors in a securities class action related to this period and highlights the approaching deadline of March 2, 2026, for those seeking to be appointed as lead plaintiff.
Investors who acquired shares during the specified timeframe are encouraged to secure legal counsel promptly to protect their rights and consider participation in the ongoing litigation initiated by Rosen Law Firm.
**Why this matters**
The March 2 deadline is critical for investors wishing to have a voice in the class action and potentially influence the direction of the case. Missing this date may result in the loss of the opportunity to serve as lead plaintiff or to participate fully in the settlement or recovery process.
Source: NewsData